BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+19.43%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$567M
AUM Growth
+$567M
(+18%)
Cap. Flow
-$7.26M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
70.26%
Holding
36
New
5
Increased
5
Reduced
14
Closed
6
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$41.9M |
| 2 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$17.6M |
| 3 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$16.7M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.68M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$8.82M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$20.6M |
| 2 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$17.1M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$8.5M |
| 4 |
Exelixis
EXEL
|
$8.36M |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$6.51M |
Sector Composition
| 1 | Healthcare | 62.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXRT
26
DELISTED
Vaxart
VXRT
| $726K | 0.13% |
350,776
| – | – |
|
|
AKAO
27
DELISTED
Achaogen, Inc.
AKAO
| $643K | 0.11% |
106,700
-29,900
| -22% | -$180K |
|
|
APTO
28
DELISTED
Aptose Biosciences, Inc.
APTO
| $538K | 0.1% |
105,429
-61,235
| -37% | -$313K |
|
|
KBIO
29
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| – | – |
-1,162,000
| Closed | -$569K |
|
|
SPHS
30
DELISTED
Sophiris Bio, Inc.
SPHS
| – | – |
-1,060,283
| Closed | -$614K |
|
|
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-1,893,030
| Closed | -$4.64M |
|
32
MEI Pharma
MEIP
$149M
| – | – |
-600,000
| Closed | -$1.07M |
|
|
33
Ligand Pharmaceuticals
LGND
$3.22B
| – | – |
-267,090
| Closed | -$20.6M |
|
|
BLRX
34
BioLineRX
BLRX
$15.8M
| – | – |
-1,501,000
| Closed | -$3.17M |
|